Related Experiment Video
Updated: Aug 9, 2026
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
[B cell abnormalities and autoantibody production in systemic sclerosis]
1Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences.
Summary
CD19, a molecule on B cells, is overexpressed in systemic sclerosis (SSc). This CD19 overexpression drives autoantibody production and fibrosis, suggesting B cells and CD19 as potential SSc therapeutic targets.
Area of Science:
- Immunology
- Rheumatology
Context:
- The role of autoantibodies in systemic sclerosis (SSc) pathogenesis is unclear.
- CD19 is a key signaling molecule in B lymphocytes, influencing B cell activation and autoantibody production.
Purpose:
- To investigate the role of CD19 in SSc pathogenesis.
- To explore the relationship between CD19 expression, autoantibody production, and fibrosis in SSc.
Summary:
- Peripheral B cells in SSc patients show increased CD19 expression.
- In a mouse model of SSc (tight-skin mice), CD19 deficiency reduces autoantibody production, skin fibrosis, and IL-6 levels.
- A model is proposed where CD19 overexpression in SSc leads to B cell tolerance breakdown, autoantibody generation, and fibrosis via cytokines like IL-6.
Impact:
- This study identifies B cells and CD19 as potential therapeutic targets for SSc.
- Understanding CD19's role may lead to novel treatments for SSc by modulating B cell activity and fibrotic processes.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...